구셀쿠맙 첫 번째 투여 후 사이클로스포린 중단에 의한 반동현상으로 악화된 건선 1예 = A Case of Rebound Phenomenon after Cessation of Cyclosporine for Guselkumab Therapy in Psoriasis

다국어 초록 (Multilingual Abstract)

Cyclosporine is one of the main therapeutic agents for psoriasis. It is known that psoriasis relapses 2∼3 monthsafter discontinuation of cyclosporine, and exacerbation due to abrupt discontinuation of cyclosporine is uncommon.
We report a case of psoriasis that was aggravated by cyclosporine cessation for guselkumab treatment, but improvedwith continuous administration of guselkumab. A 55-year-old man with a history of psoriasis presented witherythematous scaly plaques on the whole body. He had been treated with cyclosporine for 18 months and hadreceived a subcutaneous injection of guselkumab 1 month previously. Two weeks after the first injection, the patientexperienced exacerbation of the lesions. Considering the aggravation caused by abrupt discontinuation ofcyclosporine, guselkumab administration was continued. The aggravated psoriatic lesions improved after additionalguselkumab injections. At 16 weeks, the Psoriasis Area and Severity Index score was 0, which remained constantthereafter.

참고문헌 (Reference)

1 김상엽 ; 윤숙정 ; 이지범 ; 김성진 ; 원영호 ; 이승철, "중등증 내지 중증 판상건선에서 Methotrexate와Cyclosporine A의 효능 및 부작용에 대한 비교" 대한피부과학회 52 (52): 615-621, 2014

2 이광준 ; 이주흥, "경증 및 중등증 건선환자에서의 사이클로스포린 치료의 효능 및 안전성에 대한 후향적 연구" 대한피부과학회 43 (43): 1619-1625, 2005

3 강인혜 ; 신민경 ; 이무형 ; 정기헌, "Ustekinumab 치료 후 발생한 고름물집건선의 Paradoxical Flare 1예" 대한피부과학회 56 (56): 548-551, 2018

4 권륭 ; 홍규락 ; 신지연 ; 김정은 ; 박영립 ; 이상훈, "Ustekinumab 치료 후 Paradoxical Flare가 발생한 건선 환자에서 Secukinumab 치료" 대한피부과학회 58 (58): 632-634, 2020

5 Amor KT, "The use of cyclosporine in dermatology : part I" 63 : 925-946, 2010

6 Dogra S, "Secukinumab-induced paradoxical pustular psoriasis" 44 : 72-73, 2019

7 McFeely O, "Risankizumab-induced paradoxical pustular psoriasis" 47 : 616-617, 2022

8 박병철 ; Hyun Jung Lim ; 김병수 ; 이원주 ; 김도원 ; 이석종, "Repeated Paradoxical Aggravation of Preexisting Psoriasis during Infliximab Treatment for Crohn's Disease" 대한피부과학회 21 (21): 60-62, 2009

9 임지훈 ; 권순효 ; 심우영 ; 유박린, "Pustular Eruption Induced by Adalimumab in a Patient with Ankylosing Spondylitis: A Case Report" 대한피부과학회 59 (59): 394-397, 2021

10 Munera-Campos M, "Paradoxical reactions to biologic therapy in psoriasis: a review of the literature" 109 : 791-800, 2018

11 Kashlan R, "Paradoxical psoriatic arthritis flare with the initiation of brodalumab and guselkumab" 10 : 47-49, 2021

12 이호열 ; 우청하 ; 허식, "Paradoxical Flare of Psoriasis after Ustekinumab Therapy" 대한피부과학회 29 (29): 794-795, 2017

13 설정은 ; 박인호 ; 이원경 ; 김효진 ; 정소영 ; 왕한영, "Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis" 대한피부과학회 28 (28): 522-523, 2016

14 Ho VC, "Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis : a 2-year cohort study" 44 : 643-651, 2001

15 Dai YX, "Flare-up of pustular psoriasis after ustekinumab therapy : case report and literature review" 36 : 222-225, 2018

16 Mrowietz U, "A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis" 28 : 438-453, 2014

17 Oiwa T, "A case of ixekizumab-induced psoriasiform eruption" 99 : 446-447, 2019